Prescription drug · BLA
asparlas (Calaspargase pegol) NDC 72694-515
Calaspargase pegol 750 U/mL · Injection, Solution · Intravenous · Servier Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72694-515-01 | 72694051501 | 1 VIAL, SINGLE-USE in 1 CARTON (72694-515-01) / 5 mL in 1 VIAL, SINGLE-USEMarketed from Sep 27, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- asparlas
- Generic name (nonproprietary)
- calaspargase pegol
- Active ingredients
- Calaspargase pegol — 750 U/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Servier Pharmaceuticals LLCNDC labeler code 72694
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761102
- Marketing start
- Listing expires
- Other FDA classes
- Asparaginase (Chemical structure)
- Identifiers
- Product ID 72694-515_22da60ef-4135-4bd5-8af1-6d10b7879a0bSPL ID 22da60ef-4135-4bd5-8af1-6d10b7879a0bSPL set ID 6585bd0d-bd78-4341-9e87-0f7664821f05RxCUI 2121421, 2121426UNII T9FVH03HMZ
- Pharmacologic class
- Asparagine-specific Enzyme
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N472694051501followed by a unit qualifier and the quantityPackage 72694-0515-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ASPARLAS is an asparagine specific enzyme indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia in pediatric and young adult patients age 1 month to 21 years. ( 1.1 ) 1.1 Acute Lymphoblastic Leukemia ASPARLAS is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia in pediatric and young adult patients age 1 month to 21 years.
Excerpt only. Read the full label for complete information.
About NDC 72694-515
- What is NDC 72694-515?
- 72694-515 is the product NDC for asparlas (calaspargase pegol), Calaspargase pegol 750 U/mL injection, solution, listed with the FDA by Servier Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- asparlas (Calaspargase pegol).
- What is the active ingredient?
- Calaspargase pegol.
- Who is the labeler?
- Servier Pharmaceuticals LLC, NDC labeler code 72694. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for asparlas?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.